FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 2801469 · Received October 11, 2012

Report

Report Number
2017233-2012-00710
Event Type
Injury
Date Received
October 11, 2012
Date of Event
July 14, 2008
Report Date
September 17, 2012
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

LANE ET AL. (2009). AORTODUODENAL FISTULA AFTER ENDOVASCULAR ANEURYSM REPAIR PRESENTING WITH ANEURYSM SAC ABSCESS. JOURNAL OF VASCULAR SURGERY, 50, 919-920.

Description of Event or Problem · 1

ON AN UNK DATE, SOMETIME AROUND OR PRIOR TO (B)(6) 2008, THE PT UNDERWENT ENDOVASCULAR REPAIR OF A 10-CM INFRARENAL ABDOMINAL AORTIC ANEURYSM WITH GORE EXCLUDER AAA ENDOPROSTHESIS. THERE WAS NO PREOPERATIVE EVIDENCE OF AN INFLAMMATORY OR MYCOTIC ANEURYSM. A CT PERFORMED 3 MONTHS POSTOPERATIVELY SHOWED MILD PERIGRAFT STANDING WITH NO EVIDENCE OF ENDOLEAK. SIX MONTHS POST-OPERATIVELY, THE PT PRESENTED WITH FEVERS, CHILLS, LETHARGY, AND DIARRHEA. A CT SHOWED MASSIVE AMOUNTS OF AIR AROUND THE ENDOGRAFT AND WITHIN THE ANEURYSM SAC. OPERATIVE EXPLORATION REVEALED A PARAPROSTHETIC AORTODUODENAL FISTULA (ADF) WITH GROSS SUPPURATION WITHIN THE ANEURYSM SAC, WITHOUT DISTRIBUTION OF THE PROXIMAL AND DISTAL ENDOGRAFT ATTACHMENT SITES. TREATMENT INCLUDED EXTRA-ANATOMIC AXILLOBIFEMORAL BYPASS, ENDOGRAFT EXPLANTATION, ANEURYSM SAC DEBRIDEMENT, AND DUODENAL REPAIR. INTRAOPERATIVE CULTURES FROM THE ENDOGRAFT GREW BACTEROIDES FRAGILIS AND ACTINOMYCES ISRAELII. AFTER A 2-WEEK HOSPITAL COURSE, THE PT WAS DISCHARGED ON SUPPRESSIVE ANTIBIOTICS. THE PHYSICIAN INDICATED THE LARGE SIZE OF THE ANEURYSM SAC MAY HAVE CONTRIBUTED TO THE ADF DEVELOPMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE EXCLUDER AAA ENDOPROSTHESIS MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W.L. GORE & ASSOCIATES

Patients

Seq Age Sex Outcome Treatment
1 69 YR Hospitalization| L| R